Evidence map›Paper›PMID 39248340›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Ultrasound-Responsive HBD Peptide Hydrogel with Antibiofilm Capability for Fast Diabetic Wound Healing.

Lanlan Zong, Runxin Teng, Huiqi Zhang, Wenshang Liu, Yu Feng, Zhengmao Lu, Yuxiao Zhou, Zhen Fan, Meng Li, Xiaohui Pu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Smart Hydrogels in Wearable Electronics for Wound Treatments.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Treatment of diabetic wound based on hypoglycemic and antioxidant.Frontiers in bioengineering and biotechnology · 2025
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lanlan ZongState Key Laboratory of Antiviral Drugs, Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, 475004, P. R. China.
Runxin TengDepartment of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan, Road, Shanghai, 201804, P. R. China.
Huiqi ZhangState Key Laboratory of Antiviral Drugs, Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, 475004, P. R. China.
Wenshang LiuState Key Laboratory of Antiviral Drugs, Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, 475004, P. R. China.
Yu FengState Key Laboratory of Antiviral Drugs, Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, 475004, P. R. China.
Zhengmao LuDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, P. R. China.
Yuxiao ZhouDepartment of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, P. R. China.
Zhen FanDepartment of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan, Road, Shanghai, 201804, P. R. China.ORCID 0000-0003-4199-0082
Meng LiDepartment of Dermatology, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, P. R. China.ORCID 0000-0002-5896-8423
Xiaohui PuState Key Laboratory of Antiviral Drugs, Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, 475004, P. R. China.ORCID 0009-0008-0312-905X

Funding

National Natural Science Foundation of China 22075212National Natural Science Foundation of China 52222306
6 · The paper itself

Abstract

Despite advancements in therapeutic agents for diabetic chronic wounds, challenges such as suboptimal bioavailability, intricate disease milieus, and inadequate delivery efficacy have impeded treatment outcomes. Here, ultrasound-responsive hydrogel incorporated with heparin-binding domain (HBD) peptide nanoparticles is developed to promote diabetic wound healing. HBD peptide, derived from von Willebrand Factor with angiogenic activity, are first engineered to self-assemble into nanoparticles with enhanced biostability and bioavailability. Ultrasound responsive cargo release and hydrogel collapses are first verified through breakage of crosslinking. In addition, desired antioxidant and antibacterial activity of such hydrogel is observed. Moreover, the degradation of hydrogel under ultrasound stimulation into smaller fragments facilitated the deeper wound penetration of ≈400 µm depth. Complete wound closure is observed from diabetic mice with chronic wounds after being treated with the proposed hydrogel. In detail, in vivo studies revealed that hydrogels loaded with HBD peptide nanoparticles increased the levels of angiogenesis-related growth factors (VEGF-A, CD31, and α-SMA) to effectively accelerate wound repair. Overall, this study demonstrates that ultrasound-responsive HBD peptide hydrogel provides a synergistic therapeutic strategy for external biofilm elimination and internal effective delivery for diabetic wounds with biofilm infection.

Indexed as

Anti-Bacterial AgentsBiofilmsHydrogelsPeptidesWound HealingAnimalsAntioxidantsDiabetes ComplicationsDiabetes Mellitus, ExperimentalMaleMiceMice, Inbred C57BLNanoparticlesUltrasonicsvon Willebrand FactorAnti-Bacterial AgentsAntioxidantsHydrogelsPeptidesvon Willebrand Factorantibiofilmdeep deliverydiabetic woundHBD peptideultrasound‐responsive hydrogel

Identifiers

PMID39248340
PMCPMC11558141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.